CIK 0001837493 · Non-accelerated filer<br>Emerging growth company
QTREX Quantum Ltd.
Sign in to watch- Ticker
- QTEX
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- other
- Phone
- 972-9-9664488
- Business address
- HATIDHAR 2, 11TH FLOOR, RA'ANANA, Israel
- Former names
- Inspira Technologies OXY B.H.N. Ltd
- Open-market buys, last 90 days
- $180,903
- in 4 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$180,903. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-15 | Parnes Tal Director | Purchase | +6,666 | $1.50 | $10K | 766,666 |
| 2026-10-13 | Ben-Noon Dagi Shahar Chief Executive Officer | Purchase | +14,093 | $1.49 | $21K | 14,093 |
| 2026-10-09 | Ben-Noon Dagi Shahar Chief Executive Officer | Purchase | +18,181 | $1.67 | $30K | 3,664,314 |
| 2026-09-28 | Ben-Noon Dagi Shahar Chief Executive Officer | Purchase | +168,894 | $0.71 | $120K | 3,646,133 |
| 2026-08-28 | Ben-Noon Dagi Shahar Chief Executive Officer | Grant or award | +550,000 | 3,477,239 | ||
| 2026-08-28 | Parnes Tal Director | Grant or award | +550,000 | 760,000 | ||
| 2026-08-28 | Matza Sivan Director | Grant or award | +100,000 | 130,000 | ||
| 2026-08-28 | Amit Lior Director | Grant or award | +170,000 | 231,667 | ||
| 2026-08-28 | Ben-Noon Dagi Shahar Chief Executive Officer | Grant or award | +550,000 | 2,477,239 | ||
| 2026-07-06 | shabtay abraham COO | Grant or award | +550,000 | 1,882,713 | ||
| 2026-07-06 | Rozanovich Yoav Chief Business Officer | Grant or award | +550,000 | 550,000 | ||
| 2026-07-06 | Yechezkely Hayon Daniella Chief Technology Officer | Grant or award | +550,000 | 1,330,000 | ||
| 2026-07-06 | Tehila Yafit Chief Financial Officer | Grant or award | +550,000 | 1,420,000 | ||
| 2026-06-01 | Tehila Yafit Chief Financial Officer | Sale | −28,100 | $3.50 | $98K | 870,000 |
| 2026-05-29 | Yechezkely Hayon Daniella Chief Technology Officer | Sale | −50,000 | $3.00 | $150K | 780,000 |
| 2026-05-29 | Tehila Yafit Chief Financial Officer | Sale | −1,900 | $3.51 | $7K | 898,100 |
| 2026-05-29 | shabtay abraham COO and VP of R&D | Option exercise | +95,239 | $3.37 | $321K | 1,332,713 |
| 2026-05-29 | shabtay abraham COO and VP of R&D | Option exercise · Employee share options (right to buy) | −57,144 | 0 | ||
| 2026-05-29 | shabtay abraham COO and VP of R&D | Option exercise · Employee share options (right to buy) | −38,095 | 0 | ||
| 2026-05-28 | Tehila Yafit Chief Financial Officer | Sale | −15,000 | $2.56 | $38K | 915,000 |
Page 1 of 2 · 25 trades